Asensus Surgical Receives FDA 510(k) Clearance for Expansion of Machine Vision Capabilities
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has received 510(k) clearance from the FDA for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™).
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced that it has received 510(k) clearance from the FDA for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™).
ASXC, expansion, FDA, patient, surgeon, interface, medical device company, machine, Intelligent Surgical Unit™, NYSE American, new era, Guided Surgery™, 510(k) clearance, vision capabilities, Inc, Asensus Surgical, ISU™
